Fluorescence properties of methylene blue conjugated to normal/cancerous human tissues for spectral discrimination of breast cancer stages (I-IV)
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Laser-induced fluorescence (LIF) spectroscopy is utilized to differentiate normal/malignant breast cells/tissues and classify cancer stages, using the biocompatible methylene blue (MB) fluorophore. Cancerous cells (MCF-7) conjugated with MB exhibit a red-shift of 3.96 ± 0.41 nm, corresponding to ~2.5 times higher signal intensity versus normal cells (MCF-10A). Regarding stages, tissue-level fluorescence intensity is elevated ~2.5 times in stage I and ~8 times in stage IV relative to healthy ones with red-shifts ranging from 3.73 ± 0.75 nm in stage I to 18.56 ± 2.15 nm in stage IV. Thus, LIF-MB technique offers a rapid, non-invasive method for both the early detection and grading of malignant tumors. The novelty of this work arises from the synergic contribution of the LIF and gravimetric validation for breast cancer staging.
Fields of Study & Subjects
Spectroscopy Techniques in Biomedical and Chemical Research
Optical Imaging and Spectroscopy Techniques
Photodynamic Therapy Research Studies
Publication details
- Journal / source
- Figshare
- Publication date
- 30 March 2026
- Language
- EN